2-Oxoglutarate-dependent dioxygenases in cancer
JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …
[HTML][HTML] Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
Q Chen, B Yang, X Liu, XD Zhang, L Zhang, T Liu - Theranostics, 2022 - ncbi.nlm.nih.gov
The histone acetyltransferases CBP and p300, often referred to as CBP/p300 due to their
sequence homology and functional overlap and co-operation, are emerging as critical …
sequence homology and functional overlap and co-operation, are emerging as critical …
The functions of BET proteins in gene transcription of biology and diseases
KL Cheung, C Kim, MM Zhou - Frontiers in molecular biosciences, 2021 - frontiersin.org
The BET (bromodomain and extra-terminal domain) family proteins, consisting of BRD2,
BRD3, BRD4, and testis-specific BRDT, are widely acknowledged as major transcriptional …
BRD3, BRD4, and testis-specific BRDT, are widely acknowledged as major transcriptional …
Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma
Aurora kinase A (AURKA) has emerged as a drug target for glioblastoma (GBM). However,
resistance to therapy remains a critical issue. By integration of transcriptome, chromatin …
resistance to therapy remains a critical issue. By integration of transcriptome, chromatin …
[HTML][HTML] Opposing functions of BRD4 isoforms in breast cancer
Summary Bromodomain-containing protein 4 (BRD4) is a cancer therapeutic target in
ongoing clinical trials disrupting primarily BRD4-regulated transcription programs. The role …
ongoing clinical trials disrupting primarily BRD4-regulated transcription programs. The role …
JMJD family proteins in cancer and inflammation
W Manni, X Jianxin, H Weiqi, C Siyuan… - Signal transduction and …, 2022 - nature.com
The occurrence of cancer entails a series of genetic mutations that favor uncontrollable
tumor growth. It is believed that various factors collectively contribute to cancer, and there is …
tumor growth. It is believed that various factors collectively contribute to cancer, and there is …
[HTML][HTML] An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma
Characterized by intracellular lipid droplet accumulation, clear cell renal cell carcinoma
(ccRCC) is resistant to cytotoxic chemotherapy and is a lethal disease. Through an unbiased …
(ccRCC) is resistant to cytotoxic chemotherapy and is a lethal disease. Through an unbiased …
BET bromodomain inhibitors: novel design strategies and therapeutic applications
The mammalian bromodomain and extra-terminal domain (BET) family of proteins consists
of four conserved members (Brd2, Brd3, Brd4, and Brdt) that regulate numerous cancer …
of four conserved members (Brd2, Brd3, Brd4, and Brdt) that regulate numerous cancer …
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35
The majority of patients with neuroblastoma due to MYCN oncogene amplification and
consequent N-Myc oncoprotein over-expression die of the disease. Here our analyses of …
consequent N-Myc oncoprotein over-expression die of the disease. Here our analyses of …
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
Z Nagy, JA Seneviratne, M Kanikevich… - Nature …, 2021 - nature.com
To achieve the very high oncoprotein levels required to drive the malignant state cancer
cells utilise the ubiquitin proteasome system to upregulate transcription factor levels. Here …
cells utilise the ubiquitin proteasome system to upregulate transcription factor levels. Here …